NCT01351116View on ClinicalTrials.gov

A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

January 31, 2017

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

EBR plus HDRIB

EBR of 20 Gy in 5 daily fractions over one week plus HDRIB of 14 Gy in 2 fractions over two weeks

RADIATION

EBR

EBR of 20 Gy in 5 daily fractions over one week

Trial Locations (8)

Unknown

Abbotsford Centre - BC Cancer Agency, Abbotsford

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston

London Regional Cancer Centre, London

UHN-Princess Margaret Cancer Centre, Toronto

L8V 5C2

Juravinski Cancer Centre, Hamilton

N2K 2R2

Grand River Regional Cancer Centre, Kitchener

N8W 2X3

Windsor Regional Hospital Cancer Centre, Windsor

G1R 2J6

CHUQ - L'Hôtel-Dieu de Québec, Québec

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT01351116 - A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy | Biotech Hunter | Biotech Hunter